Mountain View, CA, United States of America

James W Larrick

This inventor holds 56 USPTO granted patents and 8 published patent applications and 7 EPO patents, primarily in CNS Disorders. Top assignees: Menlo Therapeutics Inc., Cetus Corporation, Panorama Research Inc.. Active years: 1986-2024.

USPTO Granted Patents = 56 (Patent Applications = 8)

% Patents Active = 62.5

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 426(Granted Patents)

Forward Citations (Not Self Cited) = 329(Dec 10, 2025)

Location History:

Mountain View, CA (US) (2010 - 2014)
Woodside, CA (US) (1986 - 2021)
Sunnyvale, CA (US) (2011 - 2024)

Company Filing History:

10 out of 10

Menlo Therapeutics Inc.

Panorama Research Inc.

Leland Stanford Junior University

patents

8. 3 out of 3

Tigercat Pharma, Inc.

patents

9. 2 out of 16

Celonova Biosciences, Inc.

Adamas Pharmaceuticals, Inc.

patents

12. 1 out of 1

Cetus Onocology Corporation

Nepenthe Bioscience LLC

patent

15. 1 out of 2

Planet Biotechnology Inc.

University of California

patents

18. 1 out of 6

Vyne Therapeutics Inc.

patents

19. 3 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

Areas of Expertise:

CNS Disorders

NK-1 Receptor Antagonists

Aminoadamantyl Nitrate

Amantadine Compounds

Anti-CD79 Antibodies

Double Allele Knock Outs

Cell Line Screening

Tissue Repair

Restenosis Prevention

Somatostatin Immunogenicity

Antioxidant Nitroxides

M-CSF Proteins

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071392 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2024-08-27),

2. 11447442 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2022-09-20),

3. 11161800 - Amantadine nitrate compounds for use as medicaments for the treatment of diseases (2021-11-02),

4. 11078276 - Anti-CD79 antibodies and their uses (2021-08-03),

5. 11060083 - Methods and compositions for producing double allele knock outs (2021-07-13),

6. 11026920 - Use of NK-1 receptor antagonist serlopitant in pruritus (2021-06-08),

7. 10816548 - Cell line screening method (2020-10-27),

8. 10702499 - Use of NK-1 receptor antagonists in pruritus (2020-07-07),

9. 10654925 - Anti-marinobufagenin antibodies and uses thereof (2020-05-19),

10. 10617671 - Use of NK-1 receptor antagonist serlopitant in pruritus (2020-04-14),

11. 10278953 - Use of NK-1 receptor antagonist serlopitant in pruritus (2019-05-07),

12. 10278952 - Use of NK-1 receptor antagonists in pruritus (2019-05-07),

13. 10214478 - Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereof (2019-02-26),

14. 9974769 - Use of NK-1 receptor antagonist serlopitant in pruritus (2018-05-22),

15. 9968588 - Use of NK-1 receptor antagonists in pruritus (2018-05-15),

Title: The Innovative Journey of James W Larrick

Introduction: James W Larrick is a renowned inventor based in Mountain View, CA, known for his groundbreaking contributions to the field of technology and healthcare.

Latest Patents: James W Larrick holds several patents in the areas of biotechnology, medical devices, and software applications, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, James W Larrick has worked tirelessly to develop cutting-edge solutions that have revolutionized the industry. His commitment to innovation has led to the creation of several groundbreaking technologies that have had a significant impact on various sectors.

Collaborations: Throughout his career, James W Larrick has collaborated with leading researchers, scientists, and industry experts to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: James W Larrick's passion for innovation and his dedication to pushing the boundaries of what is possible have established him as a key figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators and inventors.